BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27750216)

  • 1. Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer.
    Park YL; Park SY; Lee SH; Kim RB; Kim JK; Rew SY; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
    Oncotarget; 2016 Nov; 7(44):72229-72241. PubMed ID: 27750216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
    Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
    Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling.
    Kundu J; Wahab SM; Kundu JK; Choi YL; Erkin OC; Lee HS; Park SG; Shin YK
    Int J Oncol; 2012 Sep; 41(3):839-48. PubMed ID: 22710759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer.
    Zheng CH; Wang JB; Lin MQ; Zhang PY; Liu LC; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Xie JW; Li P; Huang CM
    J Exp Clin Cancer Res; 2018 Mar; 37(1):59. PubMed ID: 29540196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Recepteur d'Origine Nantais expression on chemosensitivity and tumor cell behavior in colorectal cancer.
    Kim N; Cho SB; Park YL; Park SY; Myung E; Kim SH; Yu HM; Son YA; Myung DS; Lee WS; Joo YE
    Oncol Rep; 2016 Jun; 35(6):3331-40. PubMed ID: 27035413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism.
    Yang J; Zhang K; Song H; Wu M; Li J; Yong Z; Jiang S; Kuang X; Zhang T
    Oncotarget; 2016 May; 7(22):32306-17. PubMed ID: 27058759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
    Zhong G; Li H; Shan T; Zhang N
    Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
    Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
    World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer.
    Oh HH; Park KJ; Kim N; Park SY; Park YL; Oak CY; Myung DS; Cho SB; Lee WS; Kim KK; Joo YE
    Oncol Rep; 2016 Jan; 35(1):253-60. PubMed ID: 26496979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Livin in colorectal cancer and its relationship to tumor cell behavior and prognosis.
    Myung DS; Park YL; Chung CY; Park HC; Kim JS; Cho SB; Lee WS; Lee KH; Lee JH; Joo YE
    PLoS One; 2013; 8(9):e73262. PubMed ID: 24023847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead‑box A1 regulates tumor cell growth and predicts prognosis in colorectal cancer.
    Park YL; Kim SH; Park SY; Jung MW; Ha SY; Choi JH; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
    Int J Oncol; 2019 Jun; 54(6):2169-2178. PubMed ID: 31081047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
    Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
    Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGC-1α Regulates Cell Proliferation and Invasion
    Yun SH; Park JI
    Anticancer Res; 2020 Feb; 40(2):653-664. PubMed ID: 32014906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
    Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
    Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engulfment and Cell Motility 1 (ELMO1) Regulates Tumor Cell Behavior and Predicts Prognosis in Colorectal Cancer.
    Park YL; Cho SB; Park SY; Oh HH; Myung E; Im CM; Son S; Kim S; Cho SY; Chung MW; Hong JY; Kim KH; Myung DS; Lee WS; Park D; Joo YE
    Anticancer Res; 2022 Nov; 42(11):5343-5355. PubMed ID: 36288887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.